Immune checkpoint inhibitors as a bridge to allogeneic transplantation with posttransplant cyclophosphamide

Published reports suggest that immune checkpoint inhibitors (ICIs) before allogeneic blood or marrow transplantation (alloBMT) may increase the incidence of graft-versus-host disease (GvHD), immune-related adverse events, and nonrelapse mortality (NRM); this led to the US Food and Drug Administratio...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Blood Adv
Egile Nagusiak: Schoch, Laura K., Cooke, Kenneth R., Wagner-Johnston, Nina D., Gojo, Ivana, Swinnen, Lode J., Imus, Philip, Fuchs, Ephraim J., Levis, Mark, Ambinder, Richard F., Jones, Richard J., Gladstone, Douglas E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2018
Gaiak:
Transplantation
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6134225/
https://ncbi.nlm.nih.gov/pubmed/30190282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018019208
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak